Angioplasty Balloons Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Normal Balloons, Drug Eluting Balloons, Scoring Balloons, and Cutting Balloons), Application (Peripher

Angioplasty Balloons Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Normal Balloons, Drug Eluting Balloons, Scoring Balloons, and Cutting Balloons), Application (Peripheral and Coronary), and End User (Hospitals, Ambulatory Surgery Centers, and Cath Labs)

According to our latest study on Angioplasty Balloons Market Forecast to 2030 – Global Analysis –Type, Application, End User, and Geography, the market was valued at US$ 2.71 billion in 2022 and is expected to reach US$ 3.60 billion by 2030; it is estimated to register a CAGR of 3.6% from 2022 to 2030.

An angioplasty is a technique used to widen narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, reduced revascularization rates, and lower costs compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries.

The initiative HEARTS in the Americas is led by the Ministries of Health with the participation of local stakeholders and the technical cooperation of the Pan American Health Organization (PAHO). The Initiative is being executed in more than 1,400 health centers in 22 nations across the region. By 2025, HEARTS will be the model for cardiovascular risk management, which includes diseases such as hypertension, diabetes, and dyslipidemia, in primary health care in the Americas.

Moreover, in Europe, public spending on healthcare has grown faster than domestic spending, but mainly in high-income countries. The European Commission's EU4Health program, the Next Generation Recovery Funds, and the Horizon Europe Research Funds offer an opportunity to address the burden of cardiovascular diseases and improve the cardiovascular health of citizens by implementing preventative measures identified in an EU Action Plan for better cardiovascular health. This plan covers the overall patient journey, from prevention and early detection to access to care and treatment to quality of life and functioning status, considering the vital role of digitization and innovation at all stages. Thus, increasing healthcare spending and government-led initiatives regarding heart health to create growth opportunity in angioplasty balloons market.

By Type, Angioplasty Balloons Market-Based Insights

Based on type, the angioplasty balloons market is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest angioplasty balloons market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022–2030. In endovascular therapy, drug-coated balloons (DCB), primarily paclitaxel-coated balloons, are being utilized more frequently to improve the low patency results of angioplasty. When addressing hemodialysis access dysfunction, the use of drug-eluting balloons might, in the short run, require less reintervention and associated healthcare costs than simple balloon angioplasty.

By End User, Angioplasty Balloons Market-Based Insights

The angioplasty balloons market, by end user, hospitals, ambulatory surgery centers, and others. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030, owing to the minimum hospital stay requirements and the availability of advanced services. In addition, treatments performed in ambulatory surgery centers are cost-effective, which helps cut down on total medical costs. All these factors contribute to the growth of the ambulatory surgery center segment.

European Society of World Heart Federation, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the angioplasty balloons market.